Fantastic achievement by BIO and another clinically proven product to their range! It's hard to find many companies this size with such a broad range of products. In my view it plays a big role in de-risking sales growth and they appear to be on track to beat the analysis sales forecasts so this will only further the potential upside.
Well done to the Bio Team!
Ann: Clinical trial on asthma sufferers validates Biome probiotic, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.010(2.17%) |
Mkt cap ! $100.0M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 52.0¢ | 45.5¢ | $914.1K | 1.851M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5190 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 42487 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| BIO (ASX) Chart |